Literature DB >> 23269699

Elevated cJUN expression and an ATF/CRE site within the ATF3 promoter contribute to activation of ATF3 transcription by the amino acid response.

Lingchen Fu1, Michael S Kilberg.   

Abstract

Mammalian cells respond to amino acid deprivation through multiple signaling pathways referred to as the amino acid response (AAR). Transcription factors mediate the AAR after their activation by several mechanisms; examples include translational control (activating transcription factor 4, ATF4), phosphorylation (p-cJUN), and transcriptional control (ATF3). ATF4 induces ATF3 transcription through a promoter-localized C/EBP-ATF response element (CARE). The present report characterizes an ATF/CRE site upstream of the CARE that also contributes to AAR-induced ATF3 transcription. ATF4 binds to the ATF/CRE and CARE sequences and both are required for a maximal response to ATF4 induction. ATF3, which antagonizes ATF4 and represses its own gene, also exhibited binding activity to the ATF/CRE and CARE sequences. The AAR resulted in elevated total cJUN and p-cJUN protein levels and both forms exhibited binding activity to the ATF/CRE and CARE ATF3 sequences. Knockdown of AAR-enhanced cJUN expression blocked induction of the ATF3 gene and mutation of either the ATF/CRE or the CARE site prevented the cJUN-dependent increase in ATF3-driven luciferase activity. The results indicate that both increased cJUN and the cis-acting ATF/CRE sequence within the ATF3 promoter contribute to the transcriptional activation of the gene during the AAR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269699      PMCID: PMC3568878          DOI: 10.1152/physiolgenomics.00160.2012

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  37 in total

1.  ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation.

Authors:  H Kawasaki; L Schiltz; R Chiu; K Itakura; K Taira; Y Nakatani; K K Yokoyama
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

2.  Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun.

Authors:  V R Baichwal; R Tjian
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

3.  The cell-type-specific activator region of c-Jun juxtaposes constitutive and negatively regulated domains.

Authors:  V R Baichwal; A Park; R Tjian
Journal:  Genes Dev       Date:  1992-08       Impact factor: 11.361

4.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.

Authors:  T Hai; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  Transcriptional activity of the human thymidine kinase gene determined by a method using the polymerase chain reaction and an intron-specific probe.

Authors:  K E Lipson; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Cis- and trans-acting elements involved in amino acid regulation of asparagine synthetase gene expression.

Authors:  L Guerrini; S S Gong; K Mangasarian; C Basilico
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress.

Authors:  Heather P Harding; Yuhong Zhang; Huiquing Zeng; Isabel Novoa; Phoebe D Lu; Marcella Calfon; Navid Sadri; Chi Yun; Brian Popko; Richard Paules; David F Stojdl; John C Bell; Thore Hettmann; Jeffrey M Leiden; David Ron
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

8.  Perk is essential for translational regulation and cell survival during the unfolded protein response.

Authors:  H P Harding; Y Zhang; A Bertolotti; H Zeng; D Ron
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

9.  CCAAT/enhancer-binding protein-beta is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene.

Authors:  F Siu; C Chen; C Zhong; M S Kilberg
Journal:  J Biol Chem       Date:  2001-10-24       Impact factor: 5.157

10.  Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response.

Authors:  Hao-Yuan Jiang; Sheree A Wek; Barbara C McGrath; Dan Lu; Tsonwin Hai; Heather P Harding; Xiaozhong Wang; David Ron; Douglas R Cavener; Ronald C Wek
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more
  12 in total

1.  Human CHAC1 Protein Degrades Glutathione, and mRNA Induction Is Regulated by the Transcription Factors ATF4 and ATF3 and a Bipartite ATF/CRE Regulatory Element.

Authors:  Rebecca R Crawford; Eugenia T Prescott; Charity F Sylvester; Ashlee N Higdon; Jixiu Shan; Michael S Kilberg; Imran N Mungrue
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

2.  A mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-dependent transcriptional program controls activation of the early growth response 1 (EGR1) gene during amino acid limitation.

Authors:  Jixiu Shan; Mukundh N Balasubramanian; William Donelan; Lingchen Fu; Jaclyn Hayner; Maria-Cecilia Lopez; Henry V Baker; Michael S Kilberg
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

3.  Activated Transcription Factor 3 in Association with Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression.

Authors:  Chen Li; Yu Zhou; Anastacia Loberg; Stanley M Tahara; Punam Malik; Vijay K Kalra
Journal:  Mol Cell Biol       Date:  2016-10-28       Impact factor: 4.272

4.  Activation of the amino acid response modulates lineage specification during differentiation of murine embryonic stem cells.

Authors:  Jixiu Shan; Takashi Hamazaki; Tiffany A Tang; Naohiro Terada; Michael S Kilberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-04       Impact factor: 4.310

5.  Regulation of the ATF3 gene by a single promoter in response to amino acid availability and endoplasmic reticulum stress in human primary hepatocytes and hepatoma cells.

Authors:  Jaclyn N Hayner; Jixiu Shan; Michael S Kilberg
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-02-03       Impact factor: 4.490

6.  Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes.

Authors:  Johannes Goldberg; Moritz Daniel; Yasemin van Heuvel; Marion Victor; Cordian Beyer; Tim Clarner; Markus Kipp
Journal:  Cell Mol Neurobiol       Date:  2013-08-25       Impact factor: 5.046

7.  Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.

Authors:  Thinh H Nguyen; Balakrishna Koneru; Sung-Jen Wei; Wan Hsi Chen; Monish Ram Makena; Eduardo Urias; Min H Kang; C Patrick Reynolds
Journal:  Mol Cancer Ther       Date:  2019-09-04       Impact factor: 6.009

8.  The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells.

Authors:  Michael Poppe; Sascha Wittig; Liane Jurida; Marek Bartkuhn; Jochen Wilhelm; Helmut Müller; Knut Beuerlein; Nadja Karl; Sabin Bhuju; John Ziebuhr; M Lienhard Schmitz; Michael Kracht
Journal:  PLoS Pathog       Date:  2017-03-29       Impact factor: 6.823

9.  Genomic and proteomic analysis of transcription factor TFII-I reveals insight into the response to cellular stress.

Authors:  Alex Xiucheng Fan; Giorgio L Papadopoulos; Mir A Hossain; I-Ju Lin; Jianhong Hu; Tommy Ming Tang; Michael S Kilberg; Rolf Renne; John Strouboulis; Jörg Bungert
Journal:  Nucleic Acids Res       Date:  2014-05-29       Impact factor: 16.971

10.  The induction of activating transcription factor 3 (ATF3) contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells.

Authors:  Gwang Hun Park; Jae Ho Park; Hyun Ji Eo; Hun Min Song; So Hee Woo; Mi Kyoung Kim; Jin Wook Lee; Man Hyo Lee; Jeong Rak Lee; Jin Suk Koo; Jin Boo Jeong
Journal:  BMC Complement Altern Med       Date:  2014-12-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.